Radiation Pneumonitis Clinical Trials

9 recruiting

Radiation Pneumonitis Trials at a Glance

9 actively recruiting trials for radiation pneumonitis are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Chongqing, Edinburgh, and Guangzhou. Lead sponsors running radiation pneumonitis studies include Huazhong University of Science and Technology, Instituto Nacional de Cancerologia de Mexico, and Guangdong Provincial People's Hospital.

Browse radiation pneumonitis trials by phase

Treatments under study

About Radiation Pneumonitis Clinical Trials

Looking for clinical trials for Radiation Pneumonitis? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Radiation Pneumonitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Radiation Pneumonitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Radiation Pneumonitis
Instituto Nacional de Cancerologia de Mexico72 enrolled2 locationsNCT03803787
Recruiting
Not Applicable

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

Lung CancerRadiation PneumonitisPulmonary Disease+2 more
University of Aarhus90 enrolled2 locationsNCT04676828
Recruiting
Not Applicable

Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm Clinical Study

Radiation PneumonitisLung Cancer (Including Metastatic Cancer)
The Second Affiliated Hospital of Chongqing Medical University100 enrolled1 locationNCT07339644
Recruiting

Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy

Radiation Pneumonitis
NHS Lothian5 enrolled3 locationsNCT06557343
Recruiting
Early Phase 1

FAPI PET for Lung Fibrosis

PneumoconiosisRadiation PneumonitisInterstitial Lung Disease+4 more
University of California, Los Angeles30 enrolled1 locationNCT05365802
Recruiting
Not Applicable

Hyperbaric Oxygen in the Prevention of Radiation Pneumonitis

Radiation Pneumonitis
Guangdong Provincial People's Hospital380 enrolled1 locationNCT05189496
Recruiting

Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort

Breast NeoplasmsRadiation PneumoniaRadiation Pneumonitis+1 more
Meshalkin Research Institute of Pathology of Circulation200 enrolled1 locationNCT06069115
Recruiting

Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC

NSCLCRadiation PneumonitisNintedanib
Second Hospital of Shanxi Medical University40 enrolled7 locationsNCT06570317
Recruiting

A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis

Radiation Pneumonitis
Huazhong University of Science and Technology300 enrolled3 locationsNCT05448703